Ureter Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Ureter Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial investigating pembrolizumab (MK-3475) after surgery for localized muscle-invasive bladder cancer and locally advanced urotheli…
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 trial evaluating pembrolizumab (MK-3475) after surgery for localized muscle-invasive bladder cancer and locally advanced urothelial …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer [Phase 2]
This Phase 2 trial update tests atezolizumab with or without eribulin mesylate in patients with recurrent locally advanced or metastatic uro…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery [Phase 2]
Phase 2 clinical trial evaluating gemcitabine hydrochloride and eribulin mesylate in advanced or unresectable bladder, ureter, and urethral …